Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities
Researchers analyzed multiomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinations that could be used to treat MSS CRC.